Skip to content

Clinical trials

Obesity trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Taiwan Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20055
20062
20073
20082
20094
20103
20115
20123
20134
20142
20151
20177
20188
20193
20203
202113
202210
20239
202412
202514
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Recruiting31
Unknown status26
Active, not recruiting8
Not yet recruiting4
Enrolling by invitation3
Withdrawn3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company16
National Taiwan University Hospital15
Novo Nordisk A/S14
Chang Gung Memorial Hospital10
Chung Shan Medical University8
China Medical University Hospital5
Amgen4
Taipei City Hospital4
Taipei Medical University WanFang Hospital4
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity139
Overweight51
Metabolic Syndrome18
Diabetes Mellitus, Type 213
Weight Loss9
Insulin Resistance7
Diabetes Mellitus6
Dyslipidemias6
Sleep Apnea, Obstructive6
Hypertension5

Trials

Showing 51 to 75 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.